Non-clinical safety evaluation of a novel pharmaceutical salt, rosuvastatin ethanolamine, in Wistar rats
Authors
Jigneshkumar Vaghasiya
jignesh.vaghasiya@zyduscadila.com
Toxicology Section, Department of Non-clinical Research, Zydus Research Centre, Cadila Healthcare Ltd., Ahmedabad, India
Satyam Patel
Toxicology Section, Department of Non-clinical Research, Zydus Research Centre, Cadila Healthcare Ltd., Ahmedabad, India
Sudhir Patel
Toxicology Section, Department of Non-clinical Research, Zydus Research Centre, Cadila Healthcare Ltd., Ahmedabad, India
Shekhar Kadam
Pathology Section, Department of Non-clinical Research, Zydus Research Centre, Cadila Healthcare Ltd., Ahmedabad, India
Ramchandra Ranvir
Pathology Section, Department of Non-clinical Research, Zydus Research Centre, Cadila Healthcare Ltd., Ahmedabad, India
Harilal Patel
Drug Metabolism and Pharmacokinetics Section, Department of Biopharmaceutic, Zydus Research Centre, Cadila Healthcare Ltd., Ahmedabad, India
Rajesh Sundar
Toxicology Section, Department of Non-clinical Research, Zydus Research Centre, Cadila Healthcare Ltd., Ahmedabad, India
Mukul Jain
Toxicology Section, Department of Non-clinical Research, Zydus Research Centre, Cadila Healthcare Ltd., Ahmedabad, India
Language: English
Page range: 7 - 14
Submitted on: Jan 16, 2018
Accepted on: Mar 15, 2019
Published on: Feb 20, 2020
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2020 Jigneshkumar Vaghasiya, Satyam Patel, Sudhir Patel, Shekhar Kadam, Ramchandra Ranvir, Harilal Patel, Rajesh Sundar, Mukul Jain, published by Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.